UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The KRAS -variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522

International journal of radiation oncology, biology, physics, 2016-12, Vol.96 (5), p.941-942

2016

Volltextzugriff (PDF)

Using Skin Dose Parameters Predicts Low Skin Toxicity in a Phase 2 Trial of Multiple Dwell Position Balloon-Based Brachytherapy for Partial Breast Irradiation

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S213-S213

2013

Volltextzugriff (PDF)

Early Prediction of Radiation Treatment Response via Longitudinal Analysis of CBCT Radiomic Features for Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e474-e475

2023

Volltextzugriff (PDF)

Regression of murine lung tumors by the let-7 microRNA

Oncogene, 2010-03, Vol.29 (11), p.1580-1587

2010

Volltextzugriff (PDF)

Toward Non-Operative Management of Locally Advanced Rectal Cancer Patients Undergoing Short Course Chemoradiotherapy: Early Response Prediction via Longitudinal Apparent Diffusion Coefficient

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e480-e480

2024

Volltextzugriff (PDF)

MicroRNA-Based Germline Biomarkers of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S182-S182

2024

Volltextzugriff (PDF)

Standardizing Research Training in Radiation Oncology Residency: A Pilot Program Evaluation

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e673-e674

2024

Volltextzugriff (PDF)

MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines: Implications for Pathophysiology and Therapy

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S22-S22

2011

Volltextzugriff (PDF)

The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells

Oncogene, 2009-06, Vol.28 (25), p.2419-2424

2009

Volltextzugriff (PDF)

Using MicroRNAs to Alter the Radiation Response

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S145-S146

2007

Volltextzugriff (PDF)

A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e593-e594

2024

Volltextzugriff (PDF)

MicroRNA-138 Regulation of PD-L1 Expression Immediately after Radiation is Altered by the rs4742098 Variant

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S156-S156

2018

Volltextzugriff (PDF)

Prediction of Post-chemoradiotherapy Response for Patients with Local Advanced Rectal Cancer Using Pre-treatment CT and PET Radiomics

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S31-S32

2020

Volltextzugriff (PDF)

A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S87-S88

2024

Volltextzugriff (PDF)

The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S135-S135

2024

Volltextzugriff (PDF)

MicroRNA-based Biomarkers predicting Long-Term Toxicity to Prostate SBRT

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S39-S40

2019

Volltextzugriff (PDF)

Low COX-2 Expression, But Not CD34, Predicts for Worse Overall Survival in Patients with Locally-advanced Cervical Cancer Treated with Chemoradiotherapy and Celecoxib: A Comparative Immunohistochemical Analysis of RTOG 0128

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S150-S151

2009

Volltextzugriff (PDF)

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S151-S151

2023

Volltextzugriff (PDF)

A Phase 2 Study of 5-Day Preoperative Radiotherapy for Patients With High-Risk Primary Soft Tissue Sarcoma

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S41-S41

2021

Volltextzugriff (PDF)

Changes in Gene Expression Predicting Local Control in Cervical Cancer: Results from RTOG 0128

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S16-S16

2008

Volltextzugriff (PDF)

ERCC1, COX-2, and p53 Expression in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy and Celecoxib: A Quantitative Immunohistochemical Analysis of RTOG 0128

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S355-S356

2008

Volltextzugriff (PDF)

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Oncogene, 2012-10, Vol.31 (42), p.4559-4566

2012

Volltextzugriff (PDF)

A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2014-11, Vol.25 (11), p.2230-2236

2014

Volltextzugriff (PDF)

O-43 A KRAS microRNA binding site variant is a genetic marker of risk for triple negative breast cancer

European journal of cancer supplements, 2010-09, Vol.8 (6), p.16-16

2010

Volltextzugriff (PDF)

Transcriptomic Heterogeneity in Pathological Grade Group 5 Prostate Cancer: Implications for Biomarker Discovery

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E286-E287

2019

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(8)
Radiology
(7)
Humans
(6)
Genetic Aspects
(5)
Life Sciences & Biomedicine
(5)
Oncology
(5)
Science & Technology
(5)
3' Untranslated Regions - Genetics
(4)
Apoptosis
(4)
Biochemistry & Molecular Biology
(4)
Biological And Medical Sciences
(4)
Cancer
(4)
Cell Biology
(4)
Genetics & Heredity
(4)
Human Genetics
(4)
Internal Medicine
(4)
Medical Sciences
(4)
Medicine
(4)
Medicine & Public Health
(4)
Medicine/public Health
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The KRAS -variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522

Using Skin Dose Parameters Predicts Low Skin Toxicity in a Phase 2 Trial of Multiple Dwell Position Balloon-Based Brachytherapy for Partial Breast Irradiation

Early Prediction of Radiation Treatment Response via Longitudinal Analysis of CBCT Radiomic Features for Locally Advanced Rectal Cancer

Regression of murine lung tumors by the let-7 microRNA

Toward Non-Operative Management of Locally Advanced Rectal Cancer Patients Undergoing Short Course Chemoradiotherapy: Early Response Prediction via Longitudinal Apparent Diffusion Coefficient

MicroRNA-Based Germline Biomarkers of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

Standardizing Research Training in Radiation Oncology Residency: A Pilot Program Evaluation

MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines: Implications for Pathophysiology and Therapy

The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells

Using MicroRNAs to Alter the Radiation Response

A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer

MicroRNA-138 Regulation of PD-L1 Expression Immediately after Radiation is Altered by the rs4742098 Variant

Prediction of Post-chemoradiotherapy Response for Patients with Local Advanced Rectal Cancer Using Pre-treatment CT and PET Radiomics

A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes

The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials

MicroRNA-based Biomarkers predicting Long-Term Toxicity to Prostate SBRT

Low COX-2 Expression, But Not CD34, Predicts for Worse Overall Survival in Patients with Locally-advanced Cervical Cancer Treated with Chemoradiotherapy and Celecoxib: A Comparative Immunohistochemical Analysis of RTOG 0128

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016

A Phase 2 Study of 5-Day Preoperative Radiotherapy for Patients With High-Risk Primary Soft Tissue Sarcoma

Changes in Gene Expression Predicting Local Control in Cervical Cancer: Results from RTOG 0128

ERCC1, COX-2, and p53 Expression in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy and Celecoxib: A Quantitative Immunohistochemical Analysis of RTOG 0128

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

O-43 A KRAS microRNA binding site variant is a genetic marker of risk for triple negative breast cancer

Transcriptomic Heterogeneity in Pathological Grade Group 5 Prostate Cancer: Implications for Biomarker Discovery

Suchergebnisse filtern